Are Ozempic side effects more common in females?
Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...
Channel 4 News10m
Should we be worried about deaths linked to weight loss jabs including Ozempic?
Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...
fox13now1h
Hims and Hers likely to stop selling cheaper versions of GLP-1 medications
The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...
Hands off my Ozempic! I've finally found something to keep the weight down... and I'm sick of women using it to go from slim to super-slim: SARAH VINE
Hollywood's awards season is in full swing, and one thing is becoming clear: the theme of 2025 is distinctly Hitchcockian: ...
Hims & Hers will stop selling some weight loss drugs — and the stock plummets 27%
Hims & Hers (HIMS) stock took a steep dive, dropping more than 27%Tuesday morning — even after the millennial-focused ...
In China you can get Ozempic and Wegovy within the hour for just $100 a month
MarketWatch was able to verify Zeng's claims via videos and was also able to order delivery of Ozempic to an address in China. The price was 798 yuan ($108) for a one-month supply that is injected ...
What is metformin, the old diabetes drug some people are taking for weight loss?
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
Health.com4h
Thyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?
Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
Novo Nordisk Stock Rises on Weight-Loss Retreat by Hims & Hers
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
Hims & Hers Health Shares Tumble as its Weight-Loss Treatments Face Tough Environment
Hims is pivoting after drugmaker Novo Nordisk on Friday said the Food and Drug Administration has determined that the shortage of Wegovy and Ozempic has been resolved. Compounding its challenges in ...
Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)
Hims & Hers projects $725M in GLP-1 weight loss revenue for 2025, a 3.2x increase from 2024. Read why I upgrade HIMS stock ...